(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 2.33% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.13%.
Quidelortho's revenue in 2026 is $2,593,200,000.On average, 5 Wall Street analysts forecast QDEL's revenue for 2026 to be $178,049,665,860, with the lowest QDEL revenue forecast at $169,404,479,772, and the highest QDEL revenue forecast at $184,224,798,780. On average, 5 Wall Street analysts forecast QDEL's revenue for 2027 to be $181,343,070,084, with the lowest QDEL revenue forecast at $172,286,208,468, and the highest QDEL revenue forecast at $188,204,328,884.
In 2028, QDEL is forecast to generate $191,840,796,048 in revenue, with the lowest revenue forecast at $179,902,205,736 and the highest revenue forecast at $206,523,889,880.